Newtyn Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-46,189
| Closed | -$653K | – | 42 |
|
|
2024
Q1 | $653K | Sell |
46,189
-36,121
| -44% | -$511K | 0.13% | 38 |
|
|
2023
Q4 | $620K | Sell |
82,310
-20,190
| -20% | -$152K | 0.12% | 42 |
|
|
2023
Q3 | $1.54M | Buy |
102,500
+2,500
| +3% | +$37.5K | 0.38% | 34 |
|
|
2023
Q2 | $1.59M | Sell |
100,000
-52,840
| -35% | -$840K | 0.38% | 33 |
|
|
2023
Q1 | $1.1M | Sell |
152,840
-10,660
| -7% | -$76.5K | 0.22% | 55 |
|
|
2022
Q4 | $947K | Buy |
163,500
+73,500
| +82% | +$426K | 0.2% | 53 |
|
|
2022
Q3 | $855K | Sell |
90,000
-13,500
| -13% | -$128K | 0.19% | 60 |
|
|
2022
Q2 | $1.24M | Buy |
+103,500
| New | +$1.24M | 0.24% | 57 |
|